Today's pre-market stock movers: NFLX, ASML, ROKU, ABNB and more
Gainers:
• $AlloVir (ALVR.US)$ +23.11% (announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation to its lead investigational multi-virus-specific T cell therapy posoleucel)
• $Humanigen (HGEN.US)$ +4.4% (Announces Peer-Reviewed Publication Demonstrating the Potential Clinical and Economic Benefits of Lenzilumab from the Perspective of the NHS)
Analyst comments:
Losers:
Analyst comments:
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment